---
figid: PMC2423297__zmb0110875280009
figtitle: The role of cAMP-stimulated adipogenesis via PKA- end Epac1-dependent processes
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2423297
filename: zmb0110875280009.jpg
figlink: /pmc/articles/PMC2423297/figure/f9/
number: F9
caption: Model for the role of cAMP-stimulated adipogenesis via PKA- end Epac1-dependent
  processes. Increased levels of cAMP activate both PKA- and Epac-dependent pathways.
  Activation of PKA leads to repression of Rho-kinase activity by targeting either
  the Rho-kinase or the upstream regulator Rho. High levels of Rho kinase activity
  inhibit Ins/IGF-1-dependent signaling, and attenuation of Rho-kinase activity is
  crucial for adipogenesis. However, low levels of Rho-kinase activity also enhance
  Ins/IGF-1-dependent signaling, and PKA-mediated inhibition of the Rho-kinase impairs
  Ins/IGF-1-dependent signaling. This is counteracted by the simultaneous activation
  of an Epac1/Rap1-dependent pathway, which also induces important changes in cytoskeletal
  organization, adhesion, and extracellular matrix. Activation of CREB is not dependent
  on PKA activity, but rather requires ERK activity during the initial stages of adipogenesis.
papertitle: Cyclic AMP (cAMP)-Mediated Stimulation of Adipocyte Differentiation Requires
  the Synergistic Action of Epac- and cAMP-Dependent Protein Kinase-Dependent Processes
  .
reftext: Rasmus Koefoed Petersen, et al. Mol Cell Biol. 2008 Jun;28(11):3804-3816.
year: '2008'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9710985
figid_alias: PMC2423297__F9
figtype: Figure
redirect_from: /figures/PMC2423297__F9
ndex: 6f22c29a-deb4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2423297__zmb0110875280009.html
  '@type': Dataset
  description: Model for the role of cAMP-stimulated adipogenesis via PKA- end Epac1-dependent
    processes. Increased levels of cAMP activate both PKA- and Epac-dependent pathways.
    Activation of PKA leads to repression of Rho-kinase activity by targeting either
    the Rho-kinase or the upstream regulator Rho. High levels of Rho kinase activity
    inhibit Ins/IGF-1-dependent signaling, and attenuation of Rho-kinase activity
    is crucial for adipogenesis. However, low levels of Rho-kinase activity also enhance
    Ins/IGF-1-dependent signaling, and PKA-mediated inhibition of the Rho-kinase impairs
    Ins/IGF-1-dependent signaling. This is counteracted by the simultaneous activation
    of an Epac1/Rap1-dependent pathway, which also induces important changes in cytoskeletal
    organization, adhesion, and extracellular matrix. Activation of CREB is not dependent
    on PKA activity, but rather requires ERK activity during the initial stages of
    adipogenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Shc
  - IRSp53
  - IleRS
  - chico
  - ras
  - Ras64B
  - Ras85D
  - drk
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Rok
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - PKD
  - Erk7
  - rl
  - CrebB
  - CrebA
  - Akt
  - Epac
  - Rap1
  - fzr
  - scb
  - IGF1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - ROCK1
  - ROCK2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PRKD1
  - EPHB2
  - MAPK1
  - MAPK3
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - AKT1
  - PTK2B
  - RAPGEF3
  - RAPGEF4
  - LRPAP1
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - Cancer
---
